Key result
Genetic CD43 deficiency in mice boosts post-aortic constriction survival by ~80% versus wild-type.
Why the study?
Does genetic deletion of CD43 improve survival and reduce adverse cardiac remodeling in mice with pressure overload-induced heart failure?
Does genetic deletion of CD43 improve survival and reduce adverse cardiac remodeling in mice with pressure overload-induced heart failure?
Absolute Event Rate: 90% vs 50%
Genetic deletion of CD43 improves survival and attenuates adverse cardiac remodeling in a mouse model of pressure overload-induced heart failure by modulating T cell inflammation.
Should not change HF practice; hypothesis-generating for CD43 immunomodulation in pressure-overload models.
Sialomucin CD43 is a transmembrane protein differentially expressed in leukocytes that include innate and adaptive immune cells. Among a variety of cellular processes, CD43 participates in T cell adhesion to vascular endothelial cells and contributes to the progression of experimental autoimmunity. Sequential infiltration of myeloid cells and T cells in the heart is a hallmark of cardiac inflammation and heart failure (HF). Here, we report that CD43−/− mice have improved survival to HF induced by transverse aortic constriction (TAC). This enhanced survival is associated with improved systolic function, decreased cardiac fibrosis, and significantly reduced T cell cardiac infiltration in response to TAC compared to control wild-type (WT) mice. Lack of CD43 did not alter the number of myeloid cells in the heart, but resulted in decreased cardiac CXCL10 expression, a chemoattractant for T cells, and in a monocyte shift to anti-inflammatory macrophages in vitro. Collectively, these findings unveil a novel role for CD43 in adverse cardiac remodeling in pressure overload induced HF through modulation of cardiac T cell inflammation.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2021) studied Heart failure (experimental, pressure overload-induced). CD43 genetic deficiency (CD43-/-) vs. Wild-type (WT) mice was evaluated on Survival at 28 days post-transverse aortic constriction. Genetic deficiency of CD43 in mice resulted in over 90% survival at 28 days following transverse aortic constriction compared to 50% survival in wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: